Is LH research on Rallies investment advice?

No. Rallies provides research, data, and educational context for LH. It does not provide personalized investment advice.

LH (Labcorp Holdings Inc.) Stock Analysis - Financials

Labcorp Holdings Inc. (LH) is a publicly traded Healthcare sector company. As of July 10, 2026, LH trades at $277.61 with a market cap of $22.77B and a P/E ratio of 24.38. LH moved -0.04% today. Year to date, LH is +10.66%; over the trailing twelve months it is +7.16%. Its 52-week range spans $209.38 to $293.72. Analyst consensus is strong buy with an average price target of $309.86. Rallies surfaces LH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are LH's key financials?

LH financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. LH recently traded at $277.61. Market cap is $22.77B. P/E ratio is 24.38. Revenue is $14.14B.

LH Key Metrics

Key financial metrics for LH
Metric	Value
Price	$277.61
Market Cap	$22.77B
P/E Ratio	24.38
EPS	$11.36
Dividend Yield	0.72%
52-Week High	$293.72
52-Week Low	$209.38
Volume	272.67K
Avg Volume	0
Revenue (TTM)	$14.14B
Net Income	$942.70M
Gross Margin	28.83%

LH Analyst Consensus

8 analysts cover LH: 0 strong buy, 7 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $309.86.

Common questions about LH

What are LH's key financials?: LH financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. LH recently traded at $277.61. Market cap is $22.77B. P/E ratio is 24.38. Revenue is $14.14B.
Is LH research on Rallies investment advice?: No. Rallies provides research, data, and educational context for LH. It does not provide personalized investment advice.